CNTA logo

Centessa Pharmaceuticals plc American Depositary Shares


CNTA: Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.


Show CNTA Financials

Consumer Interest
SEC Filings

Recent trades of CNTA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by CNTA's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of CNTA in WallStreetBets Daily Discussion


Recent insights relating to CNTA

CNBC Recommendations

Recent picks made for CNTA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CNTA

Corporate Flights

Flights by private jets registered to CNTA